RNS Number : 4902T
Belluscura PLC
24 June 2024
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 WHICH HAS BEEN INCORPORATED INTO UK LAW BY THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.  UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

24 June 2024

 

Belluscura plc

("Belluscura" or the "Company")

Update re proposed placing of convertible loan notes

 

Subscription for new ordinary shares to raise £300,000

 

Total voting rights

 

LONDON, U.K. AND PLANO, TX, U.S. (24 June 2024). Belluscura plc (AIM: BELL), announced on 12 June 2024 a proposed placing of convertible loan notes. The Company has received significant interest in, and demand for, the proposed placing from new and existing investors and anticipates being able to provide an update as to final terms, including the issue size, shortly.

 

Details of subscription for new ordinary shares

 

Separately, an investor has approached the Company expressing an interest in subscribing for new ordinary shares of 1 penny each in the Company ("Ordinary Shares"). Consequently, utilising the Directors' existing share authorities to issue Ordinary Shares for cash on a non-pre-emptive basis, the Company has raised gross proceeds of £300,00.00 through a subscription by such investor for, and the allotment and issue by the Company of, 2,000,000 new Ordinary Shares (the "Subscription Shares") at an issue price of 15 pence (the "Subscription Price") per Subscription Share (the "Subscription").

 

The net proceeds of the Subscription will be used for working capital purposes. The Subscription Price of 15 pence per Subscription Share represents a discount of 7.7 per cent. to the closing mid-market price of 16.25 pence per existing Ordinary Share on 21 June 2024 (being the last business day prior to this announcement).

 

Application for Admission

 

Application has been made for the Subscription Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and that dealings will commence at 8.00 a.m. on or around 25 June 2024. Once issued, the Subscription Shares will rank pari passu with the Company's existing Ordinary Shares.

 

Total voting rights

 

Following Admission, the enlarged issued share capital of the Company will comprise 167,032,567 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Consequently, 167,032,567 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

For further information please contact:

Belluscura plc

Tel: +44 (0)20 3128 8100

Adam Reynolds, Chairman


Robert Rauker, Chief Executive Officer


Simon Neicheril, Chief Financial Officer




SPARK Advisory Partners Limited - Nominated Adviser

Tel: +44 (0)20 3368 3550

Neil Baldwin / Jade Bayat




Dowgate Capital Limited - Broker

Tel: +44 (0)20 3903 7715

Russell Cook / Nicholas Chambers




MHP Group - Financial PR & Investor Relations

Tel: +44 (0)20 3128 8100

Katie Hunt / Matthew Taylor

email: Belluscura@mhpgroup.com



 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAEKDAFXLEAA